Vaccine Weekly
Susan Hasty, Publisher
Table of Contents . . . October 29th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Hantavirus Vaccine - DNA vaccine protects against hantavirus pulmonary syndrome
Lyme Disease - Galactoside is immunogenic motif in Borrelia burgdorferi sensu stricto
HIV/AIDS Vaccine - Adenoviral vector HIV vaccine stimulates enhanced mucosal IgA response
Malaria Vaccine - Vaccine based on Pichia pastoris shows promise against malaria
Smallpox - Epidemiologic, clinical, and preventive aspects of smallpox outlined
Toxoplasmosis - Dendritic cells provide protection against Toxoplasma gondii
AIDS Prevention - AIDS vaccines still elusive, but trials now include humans
Airborne Pathogens - $8.4M NIH biodefense grants to be used for development of vaccines
Anthrax - Taking aim at bioterrorism: Professor gets HHS funding
Anthrax Vaccine - Biopharm company awarded $80.3M contract for anthrax vaccine candidate
Autism - Autism rates drop in Denmark after removal of thimerosal from vaccines
Autoimmune Disease - Protein microarrays guide DNA vaccine treatment of autoimmune disease
Biological Weapons - Army study finds no illness link in biowarfare test subjects
Biosafety - University receives $18M for construction of biosafety facility
Childhood Immunization - New vaccines may address need to protect newborns in the developing world
Collaborations - Global influenza partnership signed with Sankyo
DNA Vaccine - Vaccine encoding superoxide dismutase protects against brucellosis
Drug Development - Two NIH biodefense grants to be used for vaccine development
Fascioliasis - Fatty acids bound to Fasciola hepatica differ from those in adult flukes
Finance - Vaccine company withdraws previously announced financing
Funding - Drug discovery company receives $300K in grants
HIV Prevention - $16.7M NIH contract to develop HIV vaccine
HIV Vaccine - Biopharmaceutical company awarded $19M contract to develop HIV vaccine
HIV Vaccine - Pharmaceutical company awarded contract to develop HIV vaccine
HIV Vaccine - Phase II study of Remune with HIV-infected patients begins in Italy
HIV/AIDS Vaccine - Cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination
HIV/AIDS Vaccine - SHIV 89.6 proviral DNA and live virus elicit similar immune responses
HIV/AIDS Vaccine - SIV virus-like particles conjugated to cholera toxin elicit immune responses
Hepatitis B Vaccine - Seroepidemiology of hepatitis B virus in Addis Ababa reported
Hookworm - Human hookworm maintained through 100 generations in golden hamsters
Immunization - Rural Britons consider drinking unpasteurized milk healthy
Immunology - Paper highlights preclinical results of HIV peptide vaccine
Infection - StaphVAX confirmatory-phase-III trial ahead of schedule
Influenza - CDC outlines racial/ethnic disparities in elderly vaccine recipients
Influenza - Immune response to flu shot different in people with mild symptoms of depression
Melanoma - Immunological data from phase II cancer trials of vaccine published
Mergers and Acquisitions - Net Force gains controlling interest in vaccine company in Mainland China
Mosquito-borne Disease - Veterinary vaccine candidate ChimeriVax-West Nile virus grown in mosquitoes
Pneumococcus - New vaccine for children reduces severe infection from common bacteria
Rabies - Skunk and raccoon rabies in the eastern United States followed
Respiratory Syncytial Virus - Company files Numax investigational new drug application
Rheumatoid Arthritis - IgG fusion protein BAFF-R-Fc may be better at antagonizing BAFF than BCMA-Fc
SARS - Contract awarded from NIH for development of SARS vaccine
Smallpox - Grant will be used to develop vaccine against smallpox
Vaccine Development - Smallpox Research Grid delivers research results to U.S. Defense Department
Vaccine Efficacy - Relation between vaccine efficacy and reproduction numbers explored
Vaccines - Defense appropriations bill dedicates $3M to anthrax/plague vaccine
Varicella-Zoster Virus - Herpes zoster takes larger toll than varicella in Australia
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
